Mainsail Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Mainsail Asset Management's BMY Position: Q1 2026 in Review
Mainsail Asset Management increased its Bristol-Myers Squibb (BMY) stake by 0.93% in Q1 2026, buying an estimated $3.38K and bringing the position to 6,269 shares worth $380K. The position accounts for 0.17% of the portfolio, ranked #53.
Mainsail Asset Management first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Mainsail Asset Management held 6,269 shares of Bristol-Myers Squibb worth $380K as of Q1 2026.
- Mainsail Asset Management bought 58 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.38K.
- Bristol-Myers Squibb made up 0.17% of Mainsail Asset Management's portfolio in Q1 2026, its #53 holding.
- Mainsail Asset Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Mainsail Asset Management's 13F filing for Q1 2026, filed 13 May 2026.